Status:
COMPLETED
Assessment of Adherence to Controller Inhalation Medication in Asthma- and COPD Patients.
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Asthma
COPD
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main aim of the study is to evaluate the adherence to controller inhalation medication in asthma and Chronic Obstructive Pulmonary Disease (COPD) in Universitair Ziekenhuis Brussel. Adherence will...
Detailed Description
Adherence to the controller inhalation medication is an important component of asthma and COPD care. Good adherence to the prescribed medication is asthma patients is associated with better symptom co...
Eligibility Criteria
Inclusion
- Asthmatics with treatment ≥ GINA step 2.
- COPD-patients , GOLD stage II-IV.
Exclusion
- No spirometry results available.
- COPD patients not on long-acting bronchodilators.
Key Trial Info
Start Date :
January 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 2 2019
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT03791658
Start Date
January 2 2019
End Date
May 2 2019
Last Update
May 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitair Ziekenhuis Brussel
Brussels, Brussels Capital, Belgium, 1090